Live CE/CME · Fri, Aug 14, 2026 · 12:00 PM EST

PMOS and Insulin Resistance

A root-cause approach to the syndrome formerly called PCOS

The condition has a new name — and a deeper story than cysts. In 90 minutes, learn what the PMOS rename means, why it changes how you diagnose and treat, and exactly how to reverse the root cause instead of masking symptoms — with insulin resistance at the center of roughly 85% of cases.

1.5 hr

CE/CME credit

Live

Fri, Aug 14, 2026

Lifetime access

$391.5 CE/CME · live + recording

No functional medicine background required

Session outline

6 sections · 90 min

1

Why “PCOS” became “PMOS”

2

The multisystem picture

3

Insulin resistance as the central driver

4

Diagnosis, phenotypes & functional labs

5

Root-cause protocols: nutrition, lifestyle, supplements

6

Monitoring, integration & special populations

Melody Hartzler, PharmD

Taught by Melody Hartzler, PharmD

The shift

Renaming the condition changes the conversation

For decades PMOS was framed as an ovarian, fertility problem — while insulin resistance, inflammation, and cardiometabolic risk went unaddressed. The field has now formally acknowledged the shift. The question is whether your practice reflects it.

Standard care today

What most patients still get

The condition is framed as a fertility problem, not a lifelong metabolic one

Insulin resistance goes unmeasured because fasting glucose and A1c read “normal”

Oral contraceptives and metformin manage symptoms without touching the root cause

Lean patients are told they “can’t have it” because their BMI looks fine

Patients leave feeling dismissed while long-term cardiometabolic risk compounds silently

After this course

What you’ll do differently

Explain the PMOS name change and the pathophysiology behind it with confidence

Identify insulin resistance early using functional reference ranges, even when standard labs look clean

Match treatment to phenotype instead of applying one protocol to every patient

Build lifestyle and supplement plans that restore ovulation and lower cardiometabolic risk

Position yourself as the clinician who understood the shift before it became common knowledge

The competencies

After 90 minutes, you’ll be able to

Three clinical competencies you can apply immediately.

Identify PMOS Subtypes & Diagnostic Criteria

Apply the current international diagnostic framework, distinguish the Rotterdam phenotypes and the newer data-driven subtypes, and recognize lean PMOS that conventional screening misses.

Explain the Insulin–Hormone Connection

Trace how insulin resistance drives hyperandrogenism, suppresses SHBG, disrupts ovulation, and fuels the endocrine, metabolic, and cardiovascular burden of PMOS.

Build Individualized Root-Cause Protocols

Develop phenotype-matched lifestyle and supplement strategies (inositol, NAC, targeted minerals, and more) that restore cycles and reverse insulin resistance, with realistic monitoring timelines.

Why this course was created

“For years, the label told us to look at the ovary. Meanwhile the patient in front of me had insulin resistance she was never tested for, inflammation no one addressed, and a cardiometabolic future no one was protecting.”

The rename to PMOS finally names what these women have described all along — a whole-body condition, where fertility is only one chapter. I built this session so clinicians can do more than update their vocabulary. Understand the biology, read the labs the way they should be read, and walk out with protocols you can use in your very next visit. Not theory — a repeatable, root-cause approach that changes outcomes.

Melody Hartzler, PharmD

Melody Hartzler, PharmD, BCACP, BC-ADM, ABAAHP

Course instructor

Who this is for

Built for clinicians managing women’s metabolic & reproductive health

No functional medicine background required — just an interest in treating the cause, not the label.

Pharmacists

Expanding into hormone, metabolic, and lifestyle care.

NPs & PAs

Seeing PMOS and cardiometabolic patients in primary care and women’s health.

Physicians

Family medicine, internal medicine, OB-GYN, and endocrinology.

Dietitians & Health Coaches

Supporting nutrition, supplement, and behavior change.

Clinicians Tired of the Pill-or-Wait Model

Who want an approach that actually reverses the drivers.

Anyone Whose Patients Feel Dismissed

Who wants to validate the metabolic burden these women carry.

How it’s different

Not a vocabulary update. A clinical upgrade.

Knowing PMOS is the new name is table stakes. Knowing what to do about it is the edge.

Current

Grounded in the newest consensus terminology and the research driving the name change.

Actionable

Leave with phenotype-matched protocols you can apply in your next patient visit.

Evidence-Informed

Built on the peer-reviewed literature, translated into concrete clinical decisions.

Complete curriculum · 90 minutes

What you’ll cover in 90 minutes

A structured path from the name change to the protocol.

1

Why “PCOS” Became “PMOS” 10 min

The evidence behind the rename, what it corrects, and why it changes clinical priorities.

2

The Multisystem Picture 12 min

Endocrine, metabolic, reproductive, cardiovascular, and psychological dimensions — and why cysts were never the point.

3

Insulin Resistance as the Central Driver 18 min

The insulin–androgen–follicle cascade, present in roughly 85% of cases including lean patients.

4

Diagnosis, Phenotypes & Functional Labs 20 min

Diagnostic criteria, Rotterdam and data-driven subtypes, and reading labs beyond “normal.”

5

Root-Cause Protocols: Nutrition, Lifestyle, Supplements 20 min

Phenotype-matched strategies to restore ovulation and reverse insulin resistance.

6

Monitoring, Integration & Special Populations 10 min

Realistic timelines, coordinating with conventional care, plus adolescents, lean PMOS, and fertility planning.

The takeaway

You’ll walk away with

A clear framework for diagnosing and subtyping PMOS

Confidence explaining the name change and the metabolic root cause to patients and colleagues

Phenotype-matched lifestyle and supplement protocols

A monitoring roadmap that sets realistic expectations for cycle and metabolic recovery

Course format

Flexible learning options

Attend live

Live session

Fri, Aug 14, 2026 · 12:00 PM EST

Live Q&A with the instructor

All clinicians welcome

Anytime

On-demand

1.5 hour CE/CME credit available

For pharmacists, NPs, PAs, physicians, nurses, and RDs

Lifetime access — learn at your own pace

Recording available after the live event

Melody Hartzler, PharmD

PharmD

Course instructor

Melody Hartzler, PharmD, BCACP, BC-ADM, ABAAHP

Board-Certified Clinical Pharmacist · Founder, PharmToTable & Functional Medicine CE

Melody Hartzler is a board-certified clinical pharmacist specializing in the gut, hormone, and cardiometabolic health of midlife women. She founded PharmToTable, a pharmacist-led functional medicine practice, and Functional Medicine CE, working at the intersection of functional lab interpretation, evidence-based supplementation, and root-cause care. Her clinical focus on insulin resistance and cardiometabolic health puts her at the center of what the PMOS rename is really about — and in this session she translates that expertise into protocols you can implement right away.

Good to know

Frequently asked questions

Who is eligible for CE/CME credit?

Eligible for pharmacists, physicians, NPs, PAs, nurses, and RDs. Credits are provided through our accredited continuing education partner.

Do I need a functional medicine background?

No. This session is built for clinicians at all levels. If you see women with metabolic or reproductive concerns, you can use it.

Is this just about the new name?

No. The name change is the entry point. The majority of the session is diagnosis, phenotyping, and concrete root-cause protocols you can apply.

Will this help with lean patients who don’t fit the classic picture?

Yes. A dedicated portion covers lean PMOS, where insulin resistance is present in most patients despite a normal BMI — and how to catch it.

What if I can’t attend live?

You’ll receive full on-demand access after the session, with lifetime access to the recording.

Stop treating the cyst. Start treating the cause.

The field has renamed the condition — make sure your care reflects what the new name means. Join the live session on Fri, Aug 14, 2026 at 12:00 PM ET, or catch the recording anytime.

1.5 Hour CE/CME — $39Live Fri, Aug 14, 2026 · recording + lifetime access

Best value

Get 8 hours for $249

Explore the bundle →

AMA PRA Category 1 · ACPE · AAPA · AANP · ANCC · accredited via AKH & Joint Accreditation